Nanobio and Nanomedicine

One of the company's delivery systems in the most advanced stages of clinical development is a novel drug delivery system for Paclitaxel. Because of the better safety and pharmacokinetic profile, the polymeric nanoparticle delivery system is seen as a potential super generic.

Debiopharm Group is a global biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates.

Applies nanotechnology to the design and manufacture of pumps, coatings and micro-needle arrays.

Deerac Fluidics is a global leader in microlitre and nanolitre liquid handling systems for the Life Sciences industry.

The company's NLP technology produces a generation of particles which retains the strength of the Dermazone Solutions' (SDMC) technologies, but includes the ability to produce particles of 60 nanometers to 150 nanometers which are optically clear. The use of this generation of lipid-based particle delivery system provides the ability to control the size of the final particle by controlling the number of NLPs used to assemble the finished particle. This system maintains very high loading capacity of passenger molecules and uses only safe, all natural ingredients to form both the NLPs and the final delivery system.

DiagnoCure has specialized in the development, production and commercialization of molecular diagnostics for the detection and management of cancer

A drug development company that has developed an innovative, nanotechnology-based system called NEOWATER. NEOWATER is a commercially available broad enabling platform upon which research, diagnostics, biotech and pharma companies can obtain disruptive price-performance results and overcome current technology barriers with an elegant implementation.

A specialized biomedical instrument designer, manufacturer, sales and consulting company.